Delivery Order SPE2DR25D7059-SPE2DR26F7NHS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings with a ceiling value of $1,166.19. This firm fixed-price delivery order, awarded December 16, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by December 17, 2025. The product will be performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,692.64 delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings under a firm fixed price contract. This delivery order, issued on January 5, 2026, with an ultimate completion date of January 6, 2026, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award utilized no set-aside designation, indicating it was competitively awarded. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings valued at $1,255.38. This competitively awarded, firm fixed-price delivery order was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under a larger procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings valued at $2,615.28 under a firm fixed-price contract. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is...
- The Defense Logistics Agency (DLA) awarded a $12,219.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings, with an ultimate completion date of September 23, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $1,345.05 delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on August 11, 2025, with completion by August 12, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $8,043.85 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and represents a routine pharmaceutical procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,076.04 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings under a firm fixed price contract. This delivery order, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a child contract action under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The award carries no set-aside designation, indicating it was competitively awarded. Performance...
- The Defense Logistics Agency awarded a $1,345.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings, with an ultimate completion date of September 15, 2025. This non-set-aside award was issued on September 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a critical...
- The Defense Logistics Agency has awarded a delivery order valued at $6,518.56 to AmerisourceBergen Drug Corp for the supply of etonogestrel-ethinyl estradiol vaginal rings, a hormonal contraceptive product. This non-set-aside, firm fixed price delivery order was awarded on December 15, 2025, with an ultimate completion date of December 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- SPE2DR25D7059Indefinite Delivery Contract
- SPE2DR25D7059-SPE2DR26F7NHSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings, with a ceiling value of $1,736.20 and a firm fixed price structure. The award was made on January 5, 2026, with an ultimate completion date of January 6, 2026, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division, serving as a critical pharmaceutical distributor for federal medical procurement needs. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, medical devices, and healthcare commodities to military healthcare systems and other federal agencies. The etonogestrel-EE vaginal ring delivery reflects the company's role in supplying specialized pharmaceutical products across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/4/26 |